Bloomberg Markets: Nierengarten on Small, Mid-Market Biotech

Bloomberg Markets with Carol Massar and Cory Johnson. GUEST: David Nierengarten Head of Health Care Equity Research Wedbush Securities Discussing investing in biotech stocks, inlcuding Blueprint Medicines.

2356 232

Bloomberg Markets: Nierengarten on Small, Mid-Market Biotech7 years ago

11:00

Suggested Podcasts

Bestbookbits

Slate Books

Could It Be Oak Island Podcast

DemiGoddess

Wholehearted: Love, Life + Intimacy

What Are We Building? Sun Prairie

Purple Love Stories

Gender, Religion and Caste Explanation by Dr Meghna Vig

Effective English

Phirse

Download the app

Get it on Google Play Available on the App Store

lystn

Bloomberg Markets: Nierengarten on Small, Mid-Market Biotech

Suggested Podcasts

Please complete your sign-in

Download the app